John Francis Leader
Research Subjects
John Francis Leader has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Astrid Chevance
Public Health Paris Université Paris-Cité
1 shared publicationBarbara Clyne
Department of Public Health and Epidemiology Dublin Leinster Royal College of Surgeons in Ireland Division of Population Health Sciences
1 shared publication- Brendan Rooney
University College Dublin
1 shared publication Caroline Walsh
Dublin National Centre for Pharmacoeconomics
1 shared publication- Conor Teljeur
Health Technology Assessment (HTA) Directorate Dublin Health Information and Quality Authority
1 shared publication David Byrne
Department of Health Psychology, School of Population Health Dublin Leinster Royal College of Surgeons in Ireland Division of Population Health Sciences
1 shared publication
Latest Publications
- Open Access
- 10 October 2026
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 9, 104
RENOVATE Healthcare Ireland & Ukraine: Economic protocol for comparative cost-effectiveness of available health interventions for depression, according to symptom severity
Background Depression is a leading cause of disability worldwide, associated with reduced quality-of-life and significant economic costs. While NICE has recommended first-line pharmacological, psychological and physical interventions for adults with less severe (subthreshold/mild) and more severe (moderate/severe) depression within a shared decision-making framework (NICE 2022), comparative cost-effectiveness has not been established from Irish or Ukrainian perspectives, two countries with different healthcare systems that currently lack national cost-effectiveness evidence. Aim To estimate the comparative cost-effectiveness of first-line depression treatments for adults with less severe and more severe depression from Irish and Ukrainian perspectives, following NICE treatment recommendations. Methods A cost-effectiveness analysis comparing pharmacological, psychological and physical interventions for less severe and more severe depression will be conducted from Irish and Ukrainian perspectives, following CHEERS guidelines, using clinical effectiveness inputs from the network meta-analysis (NMA) underpinning NICE NG222. Two independent models will be developed, one per severity stratum, each parameterised with population-specific inputs, consistent with NICE methods. In Phase 1 (primary outcome, 8–12 weeks), NMA standardised mean differences will be converted to numbers needed to treat (NNT) and combined with activity-based micro-costing to calculate incremental cost-effectiveness ratios as cost per additional patient in remission versus treatment as usual (less severe) or pill placebo (more severe depression). Depression-free days (DFDs) will be reported as a secondary outcome. In Phase 2 (secondary outcome, 2 years), a decision tree linked to a three-state Markov model (remission, depressive episode, death) will estimate cost per quality-adjusted life year (QALY) gained. Phase 2 primary findings will be presented for Ireland, with exploratory analysis for Ukraine. DFDs will be estimated from modelled time in remission. Uncertainty will be characterised through Probabilistic Sensitivity Analysis. Results and expected impact Results will provide policy-relevant economic evidence on first-line depression treatments across two distinct European healthcare systems, supporting evidence-based resource allocation.
- 10 October 2026
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 9, 104
Open AccessRENOVATE Healthcare Ireland & Ukraine: Economic protocol for comparative cost-effectiveness of available health interventions for depression, according to symptom severity
Background Depression is a leading cause of disability worldwide, associated with reduced quality-of-life and significant economic costs. While NICE has recommended first-line pharmacological, psychological and physical interventions for adults with less severe (subthreshold/mild) and more severe (moderate/severe) depression within a shared decision-making framework (NICE 2022), comparative cost-effectiveness has not been established from Irish or Ukrainian perspectives, two countries with different healthcare systems that currently lack national cost-effectiveness evidence. Aim To estimate the comparative cost-effectiveness of first-line depression treatments for adults with less severe and more severe depression from Irish and Ukrainian perspectives, following NICE treatment recommendations. Methods A cost-effectiveness analysis comparing pharmacological, psychological and physical interventions for less severe and more severe depression will be conducted from Irish and Ukrainian perspectives, following CHEERS guidelines, using clinical effectiveness inputs from the network meta-analysis (NMA) underpinning NICE NG222. Two independent models will be developed, one per severity stratum, each parameterised with population-specific inputs, consistent with NICE methods. In Phase 1 (primary outcome, 8–12 weeks), NMA standardised mean differences will be converted to numbers needed to treat (NNT) and combined with activity-based micro-costing to calculate incremental cost-effectiveness ratios as cost per additional patient in remission versus treatment as usual (less severe) or pill placebo (more severe depression). Depression-free days (DFDs) will be reported as a secondary outcome. In Phase 2 (secondary outcome, 2 years), a decision tree linked to a three-state Markov model (remission, depressive episode, death) will estimate cost per quality-adjusted life year (QALY) gained. Phase 2 primary findings will be presented for Ireland, with exploratory analysis for Ukraine. DFDs will be estimated from modelled time in remission. Uncertainty will be characterised through Probabilistic Sensitivity Analysis. Results and expected impact Results will provide policy-relevant economic evidence on first-line depression treatments across two distinct European healthcare systems, supporting evidence-based resource allocation.
- Open Access
- 22 February 2024
- Published by Springer Nature in Virtual Reality
- Vol. 28 (1) , 1-20
Social VR design features and experiential outcomes: narrative review and relationship map for dyadic agent conversations
The application of virtual reality to the study of conversation and social interaction is a relatively new field of study. While the affordances of VR in the domain compared to traditional methods are promising, the current state of the field is plagued by a lack of methodological standards and shared understanding of how design features of the immersive experience impact participants. In order to address this, this paper develops a relationship map between design features and experiential outcomes, along with expectations for how those features interact with each other. Based on the results of a narrative review drawing from diverse fields, this relationship map focuses on dyadic conversations with agents. The experiential outcomes chosen include presence & engagement, psychological discomfort, and simulator sickness. The relevant design features contained in the framework include scenario agency, visual fidelity, agent automation, environmental context, and audio features. We conclude by discussing the findings of the review and framework, such as the multimodal nature of social VR being highlighted, and the importance of environmental context, and lastly provide recommendations for future research in social VR.
- 22 February 2024
- Published by Springer Nature in Virtual Reality
- Vol. 28 (1) , 1-20
Open AccessSocial VR design features and experiential outcomes: narrative review and relationship map for dyadic agent conversations
The application of virtual reality to the study of conversation and social interaction is a relatively new field of study. While the affordances of VR in the domain compared to traditional methods are promising, the current state of the field is plagued by a lack of methodological standards and shared understanding of how design features of the immersive experience impact participants. In order to address this, this paper develops a relationship map between design features and experiential outcomes, along with expectations for how those features interact with each other. Based on the results of a narrative review drawing from diverse fields, this relationship map focuses on dyadic conversations with agents. The experiential outcomes chosen include presence & engagement, psychological discomfort, and simulator sickness. The relevant design features contained in the framework include scenario agency, visual fidelity, agent automation, environmental context, and audio features. We conclude by discussing the findings of the review and framework, such as the multimodal nature of social VR being highlighted, and the importance of environmental context, and lastly provide recommendations for future research in social VR.
- 1 August 2018
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-9
Mixed Reality Therapy Clinic Design
The traditional layout of a psychotherapy room is typically drawn from the earlier part of the last century. With the growing availability of immersive multimedia technologies, and the need for applied forms of learning, the design of a mixed reality technology-assisted practice is considered, and ergonomic and workflow factors are explored. Three suggested layout templates are contrasted, and it is proposed that an optimized mixed reality therapy clinic should retain the familiarity of the classic model while at the same time be configured in a way that is amenable to the many benefits of immersive technology.
- 1 August 2018
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-9
Mixed Reality Therapy Clinic Design
The traditional layout of a psychotherapy room is typically drawn from the earlier part of the last century. With the growing availability of immersive multimedia technologies, and the need for applied forms of learning, the design of a mixed reality technology-assisted practice is considered, and ergonomic and workflow factors are explored. Three suggested layout templates are contrasted, and it is proposed that an optimized mixed reality therapy clinic should retain the familiarity of the classic model while at the same time be configured in a way that is amenable to the many benefits of immersive technology.